The role of liposomes in clinical nanomedicine development. What now? Now what?

Authors :: Crommelin DJA
van Hoogevest P
Storm G
Source :: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2020 Feb; Vol. 318, pp. 256-263. Date of Electronic Publication: 2019 Dec 14.
Publication Year :: 2020
Abstract: The rapid rise in interest in 'nanomedicines' in the academic world over the last twenty years and the claims of success led to calls for reflection. The main body of text of this Commentary will be on answering the question: 'where to go with nanomedicines'? Research priorities for the future will be outlined based on experience with the most successful nanomedicines family within the broad field of nanomedicine so far: liposomes. An analysis of currently clinically tested, approved and marketed liposome-drug combinations provides these insights.<br /> (Copyright © 2019 Elsevier B.V. All rights reserved.)

Language :: English
ISSN :: 1873-4995
Volume :: 318
Database :: MEDLINE
Journal :: Journal of controlled release : official journal of the Controlled Release Society
Publication Type :: Academic Journal
Accession number :: 31846618
Full Text :: https://doi.org/10.1016/j.jconrel.2019.12.023